California Prescription Drug Monitoring Program: Managing Prescription Drug Abuse

Article Contents

Managing Prescription Drug Abuse

Article Contents

The Controlled Substance Utilization Review and Evaluation System (CURES), California’s prescription drug monitoring program, was established to combat the adverse effects of prescription drug abuse across the state. The program aims to accomplish this goal by promoting prescription drug safety and educating Californians on the dangers of prescription drugs.

What is Drug Diversion? 

Not to be confused with programs that offer first-time offenders the chance to attend treatment instead of serving a jail sentence, drug diversion refers to the exchange of prescription drugs from the individual with the prescription to another party.

Within the CURES program, the term “drug diversion” refers specifically to this illegal exchange of prescription medications. This includes transactions from a prescription holder to a nonprescription-holder, as well as the general trade of controlled prescription drugs without a valid prescription.

Controlled Substance Utilization Review And Evaluation

CURES were established in 1997 as a possible replacement for the California Triplicate Prescription Program (TPP), the original program founded to gather Schedule II prescription drug data in California. From 1997 to 1999, the two programs ran concurrently. When it was found that CURES was more effective at identifying instances of “doctor shopping” and prescription drug abuse, the CURES program was selected as the standalone monitoring program for the entire state.

Highlights Of The Cures Prescriptions Drug Monitoring Program

What Drugs Are Monitored By California’s Prescription Drug Monitoring Program?

Currently, CURES stores and reports all dispensation data for controlled substances Schedules II (2), III (3) and IV (4).


According to California Health and Safety Code Section § 11165 (c), CURES PDMP data:

“…May be provided to public or private entities, as approved by the Department of Justice, for educational, peer review, statistical, or research purposes, provided that patient information, including any information that may identify the patient, is not compromised.”

What this means is that the only ones with access to the data are those approved to have access, such as doctors, pharmacists, etc. in addition to agencies (that have been approved) using it for statistics and research. Not all physicians are required to use the data, and only doctors that have been approved will have access.


  • Pharmacists are required to report dispensations of controlled substances weekly.
  • The Department of Justice does not modify any of the information within the system.
  • Over 100 million entries have been entered into the California database.
  • From 2011 to 2012, the program responded to 1,063,952 requests.
  • In 2015, partially in response to the ongoing opioid epidemic, CURES 2.0 was introduced to further fight drug diversion and assist in stemming the nationwide abuse of opioids.
  • With CURES 2.0, prescribers were given the ability to create alert messages within the system. This feature allows doctors and pharmacists to alert each other about patients of concern, and can greatly reduce instances of “doctor shopping” when used properly.
  • The CURES system also helps to track the dosages of methadone given to patients with addictions, identifying previous instances of methadone abuse that had gone overlooked.
  • CURES 2.0 provide prescribers with information on patients who are or were previously prescribed opioids or benzodiazepines. A deadly combination, mixing these two types of medications greatly increases the likelihood of accidental, deadly overdose. This goal of these alerts is to protect patients from accidentally mixing the two drugs if two different prescribers prescribed them independently.

Shortfalls of Prescription Drug Monitoring Programs 

While the presence of prescription drug monitoring programs is essential in modern times, and has undoubtedly saved numerous lives, prescription drug abuse, overdoses, and black market sales of RX drugs remains prevalent. A few shortfalls of the system include the fact that the PDMP are still running on a state-by-state basis, with each state responsible for implementing a PDMP, and ensuring that the various state programs “speak” to each other.

Some have said that the biggest shortfall of PDMPs is that they cannot judge pain levels, and that some patients have been “cut off” from their pain medications even though their pain levels are beyond manageable without the drugs. Additionally, some argue that the lax prescription practices of earlier years led to people getting addicted to various prescription drugs, and that the new systems restrict access without diverting these individuals to addiction treatment. The current heroin epidemic in the United States gives credence to this theory, with many heroin users surveyed in the United States stating that they turned to heroin after they no longer acquire prescription painkillers due to PDMP restrictions.

Addiction Treatment for California Prescription Drug Addictions

With CURES already in-place, it is becoming more difficult for California residents to actively abuse prescription drugs. If you do have a current addiction to prescription drugs, or find yourself unable to stop taking a drug that has been prescribed to you by your doctor, it is essential that you seek treatment immediately. Prescription drug addiction can be stopped, and you can live a pain-free and comfortable life without drugs with the help of addiction treatment.

This page does not provide medical advice.
  • This field is for validation purposes and should be left unchanged.

Questions About Treatment?

Elevate Rehab offers 100% confidential substance abuse assessment and treatment placement tailored to your individual needs. Achieve long-term recovery.

Treatment Resources

Popular treatment programs